South & Central America Structural Heart Market Forecast to 2028 - Regional Analysis - by Product (Occluders, Annuloplasty Rings, Heart Valve Balloons, and Others), Procedure (Heart Valve Stenosis, Heart Valve Regurgitation, and Left Atrial Appendage Closure), and End User (Hospitals, Ambulatory Surgical Centers, and Cardiac Centers)
The South & Central America structural heart market is expected to grow from US$ 770.68 million in 2023 to US$ 1,148.35 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2023 to 2028.
Rising Number of Cardiovascular Disease Cases and Training Programs Fuel South & Central America Structural Heart Market
According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death South & Central America. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.
South & Central America Structural Heart Market Overview
The South and Central America structural heart is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to register the largest market share in this region during the forecast period. The flourishing medical tourism sector and growing government initiatives to create awareness about modern healthcare products are the factors contributing to the structural heart market growth in South & Central America. Additionally, the rising prevalence of cardiovascular diseases and hypertension is propelling the structural heart market growth in the region.
South & Central America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Structural Heart Market Segmentation
The South & Central America structural heart market is segmented into product, procedure, end user, and country.
Based on product, the South & Central America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the South & Central America structural heart market in 2022.
Based on procedure, the South & Central America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the South & Central America structural heart market in 2022.
Based on end user, the South & Central America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the South & Central America structural heart market in 2022.
Based on country, the South & Central America structural heart market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America structural heart market in 2022.
Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Braile Biomedica Industry, Commerce and Representations Ltd are some of the leading companies operating in the South & Central America structural heart market.
Rising Number of Cardiovascular Disease Cases and Training Programs Fuel South & Central America Structural Heart Market
According to the World Health Organization (WHO), cardiovascular diseases are the second leading cause of death South & Central America. Therefore, various initiatives are being taken to control cardiovascular diseases. Heart valve disease is expected to be one of the most common causes of heart failure. Degenerative diseases of aortic and mitral valves, and diseases of dysfunctional tricuspid valves lead to a worse clinical course in severe cases. Minimally invasive, surgical, and catheter-based interventions for structural heart disease have increased dramatically recently. The structural heart is an evolving field consisting of heart valve surgeries and transcatheter procedures; therefore, various training programs are being arranged for cardiac surgeons and physicians. Over the past decade, the burgeoning incidence of structural heart disease has necessitated the development of formal training programs to ensure the appropriate competency of workforces. The structure, length, and scope of training vary greatly between programs. Most programs provide solid exposure on transcatheter aortic valve replacement (TAVR) procedures, simultaneously providing a lesser and variable experience of atrial septal or ventricular septal defect closure, left atrial appendage closure, and congenital heart defect interventions. With the advent of TAVR, the MitraClip mitral valve repair system (Abbott Vascular), and left atrial appendage occlusion (LAAO) procedures, there has been a significant increase in the volume of structural cardiac procedures performed for treating patients with complex cardiovascular conditions. Many organizations have developed services and procedural offerings in an organized format for the structural cardiac program to accommodate the influx of patients. Training in SHD is exciting, challenging, and rewarding overall. As the field evolves, standardization of SHD training becomes extremely important to ensure the best quality of patient care. Finding a mentor to help navigate the numerous considerations outlined can be the best asset to successfully transitioning from training to practice.
South & Central America Structural Heart Market Overview
The South and Central America structural heart is segmented into Brazil, Argentina, and the Rest of South & Central America. Brazil is expected to register the largest market share in this region during the forecast period. The flourishing medical tourism sector and growing government initiatives to create awareness about modern healthcare products are the factors contributing to the structural heart market growth in South & Central America. Additionally, the rising prevalence of cardiovascular diseases and hypertension is propelling the structural heart market growth in the region.
South & Central America Structural Heart Market Revenue and Forecast to 2028 (US$ Million)
South & Central America Structural Heart Market Segmentation
The South & Central America structural heart market is segmented into product, procedure, end user, and country.
Based on product, the South & Central America structural heart market is segmented into occluders, annuloplasty rings, heart valve balloons, and others. The occluders segment held the largest share of the South & Central America structural heart market in 2022.
Based on procedure, the South & Central America structural heart market is segmented into heart valve stenosis, heart valve regurgitation, and left atrial appendage closure. The heart valve stenosis segment held the largest share of the South & Central America structural heart market in 2022.
Based on end user, the South & Central America structural heart market is segmented into hospitals, ambulatory surgical centers, and others. The hospitals segment held the largest share of the South & Central America structural heart market in 2022.
Based on country, the South & Central America structural heart market is segmented into the Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America structural heart market in 2022.
Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, Artivion Inc, Edwards Lifesciences Corp, and Braile Biomedica Industry, Commerce and Representations Ltd are some of the leading companies operating in the South & Central America structural heart market.
1. INTRODUCTION
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Structural Heart Market - by Product
1.3.2 South & Central America Structural Heart Market - by Procedure
1.3.3 South & Central America Structural Heart Market - by End User
1.3.4 South & Central America Structural Heart Market - by Country
2. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. STRUCTURAL HEART MARKET - SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Structural Heart Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY PRODUCT
7.1 Overview
7.2 South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY PROCEDURE
8.1 Overview
8.2 South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY END USER
9.1 Overview
9.2 South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 -COUNTRY ANALYSIS
10.1 South & Central America South & Central America Structural Heart Market
10.1.1 Overview
10.1.2 South & Central America: South & Central America Structural Heart Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Brazil: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.1.4 Brazil: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.1.4.1 Brazil: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.1.4.2 Brazil: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.1.5 Brazil: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Argentina: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.2.4 Argentina: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.2.4.1 Argentina: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.2.4.2 Argentina: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.2.5 Argentina: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.3 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South & Central America: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.3.4 Rest of South & Central America: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.3.4.1 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.3.4.2 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.3.5 Rest of South & Central America: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
11. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 South & Central America Structural Heart Market - by Product
1.3.2 South & Central America Structural Heart Market - by Procedure
1.3.3 South & Central America Structural Heart Market - by End User
1.3.4 South & Central America Structural Heart Market - by Country
2. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - KEY TAKEAWAYS
3. RESEARCH METHODOLOGY
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - MARKET LANDSCAPE
4.1 Overview
4.2 PEST Analysis
4.2.1 South & Central America PEST Analysis
4.3 Expert’s Opinion
5. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - KEY MARKET DYNAMICS
5.1 Market Drivers
5.1.1 Availability of Innovative Structural Heart Services
5.1.2 Rising Number of Cardiovascular Disease Cases and Training Programs
5.2 Key Market Restraints
5.2.1 High Cost of Procedures
5.2.2 Stringent Regulations Regarding Structure Heart Devices
5.3 Key Market Opportunities
5.3.1 Growing Use of Artificial Intelligence in Structural Heart
5.4 Future Trends
5.4.1 Technological Advancements in the Field of Structural Heart Devices
5.5 Impact analysis
6. STRUCTURAL HEART MARKET - SOUTH & CENTRAL AMERICA ANALYSIS
6.1 South & Central America Structural Heart Market Revenue Forecast and Analysis
7. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY PRODUCT
7.1 Overview
7.2 South & Central America Structural Heart Market Revenue Share, by Product 2021 & 2028 (%)
7.3 Occluders
7.3.1 Overview
7.3.2 Occluders: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.4 Annuloplasty Rings
7.4.1 Overview
7.4.2 Annuloplasty Rings: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.5 Heart Valve Balloons
7.5.1 Overview
7.5.2 Heart Valve Balloons: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
7.6 Others
7.6.1 Overview
7.6.2 Others: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY PROCEDURE
8.1 Overview
8.2 South & Central America Structural Heart Market Revenue Share, by Procedure 2021 & 2028 (%)
8.3 Heart Valve Stenosis
8.3.1 Overview
8.3.2 Heart Valve Stenosis: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.4 Heart Valve Regurgitation
8.4.1 Overview
8.4.2 Heart Valve Regurgitation: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
8.5 Left Atrial Appendage Closure
8.5.1 Overview
8.5.2 Left Atrial Appendage Closure: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 - BY END USER
9.1 Overview
9.2 South & Central America Structural Heart Market Revenue Share, by End User 2021 & 2028 (%)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.4 Ambulatory Surgical Centers
9.4.1 Overview
9.4.2 Ambulatory Surgical Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
9.5 Cardiac Centers
9.5.1 Overview
9.5.2 Cardiac Centers: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET - REVENUE AND FORECAST TO 2028 -COUNTRY ANALYSIS
10.1 South & Central America South & Central America Structural Heart Market
10.1.1 Overview
10.1.2 South & Central America: South & Central America Structural Heart Market, by Country, 2021 & 2028 (%)
10.1.2.1 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Brazil: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.1.3 Brazil: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.1.4 Brazil: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.1.4.1 Brazil: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.1.4.2 Brazil: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.1.5 Brazil: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 Argentina: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.2.3 Argentina: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.2.4 Argentina: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.2.4.1 Argentina: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.2.4.2 Argentina: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.2.5 Argentina: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
10.1.2.3 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 Rest of South & Central America: South & Central America Structural Heart Market - Revenue and Forecast to 2028 (US$ Million)
10.1.2.3.3 Rest of South & Central America: South & Central America Structural Heart Market, by Product, 2019-2028 (USD Million)
10.1.2.3.4 Rest of South & Central America: South & Central America Structural Heart Market, by Procedure, 2019-2028 (USD Million)
10.1.2.3.4.1 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Stenosis Procedure, 2019-2028 (USD Million)
10.1.2.3.4.2 Rest of South & Central America: South & Central America Structural Heart Market, by Heart Valve Regurgitation Procedure, 2019-2028 (USD Million)
10.1.2.3.5 Rest of South & Central America: South & Central America Structural Heart Market, by End User, 2019-2028 (USD Million)
11. SOUTH & CENTRAL AMERICA STRUCTURAL HEART MARKET-INDUSTRY LANDSCAPE
11.1 Overview
11.2 Growth Strategies
11.2.1 Overview
12. COMPANY PROFILES
12.1 Abbott Laboratories
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Medtronic Plc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Boston Scientific Corp
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Artivion Inc
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Edwards Lifesciences Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Braile Biomedica Industry, Commerce and Representations Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. APPENDIX
13.1 About The Insight Partners
13.2 Glossary of Terms
